Latest Breaking News On - Retina research institute - Page 1 : vimarsana.com

David Lally, MD: Perspective on ANX007 for Geographic Atrophy

At AAO 2023, David Lally, MD describes results from the phase 2 ARCHER study and the potential benefit of intravitreal ANX007 for patients with GA.

United statesSan franciscoDavid lallyAmerican academy of ophthalmologyAnnual american academyRetina research instituteNew england retina consultants

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023 - EyePoint Pharmaceuticals (NASDAQ:EYPT)

WATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with retinal

United statesUniversity of massachusetts medical schoolJays dukerChristina tartagliaAmy phillipsDavidr lallyDavids boyerKeck school of medicineEyepoint pharmaceuticals incGreen room communicationsEquinox sciencesVitreous associates medical groupRetinal surgeon at baystate medical centerEyepoint pharmaceuticalsPoint pharmaceuticalsChief executive officer

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of massachusetts medical schoolDavidr lallyDavids boyerJays dukerChristina tartagliaAmy phillipsEyepoint pharmaceuticals nasdaqKeck school of medicineRetinal surgeon at baystate medical centerEyepoint pharmaceuticalsEquinox sciencesVitreous associates medical groupGreen room communicationsEyepoint pharmaceuticals incPoint pharmaceuticals

David Lally, MD: Efficacy of Oral APX3330 for Diabetic Retinopathy

Presented at ASRS 2023, results from the phase 2 ZETA-1 trial showed oral APX3330 missed its primary endpoint, but the consideration of a binocular treatment effect may warrant further clinical development.

United statesDavid lallyAmerican society of retina specialistsAmerican societyRetina specialistsAnnual meetingRetina research instituteNew england retina consultants

Geographic Atrophy Overview

Ryan Haumschild, PharmD, MS, MBA, opens a discussion surrounding the disease landscape of geographic atrophy.

United statesMaria lopesDavid lallyRyan haumschildArshad khananiWinship cancer instituteSierra eye associatesPeer exchangeGeographic atrophyEmory healthcareRetina research instituteNew england retina consultantsMacular degenerationNeovascular age related degenerationCentral vision loss